Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +3.60% | +5.65% | +596.46% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 4.000 | 5.170 | 5.130 |
Spread/Res. | -6.50% | -27.66% | -27.10% |
Spread/Supp. | +14.02% | +139.74% | +154.42% |
Support | 3.280 | 1.560 | 1.470 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ELEV Stock
- Charts Elevation Oncology, Inc.